首页> 外文期刊>Endocrine journal >Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT
【24h】

Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT

机译:US扫描和99mTc-MIBI SPECT / CT手术治疗甲状旁腺功能亢进的策略

获取原文
       

摘要

References(22) Cited-By(8) We evaluated the efficacy of technetium-sestamibi (99m Tc-MIBI) SPECT/CT for planning parathyroidectomy in cases with primary hyperparathyroidism (pHPT), comparing with planar scintigraphy and ultrasound (US), in an aim to establish the proper surgical strategy according to the preoperative imaging studies. A retrospective review of consecutive 75 pHPT patients who had been operated on was conducted. The results of preoperative imaging modalities and the operative finding were analyzed. Seven cases were found to have multiple hyperplastic glands, and no responsible gland was found in three cases. Four cases underwent only US scan for preoperative imaging. Remaining 61 cases were found to have single adenoma, and were included in the evaluation of localization imaging. US scan, 99m Tc-MIBI planar scan and 99m Tc-MIBI SPECT/CT showed accurate localization in 77.0% (47/61), 75.4% (46/61) and 88.5% (46/52) of the evaluable cases, respectively. US and 99m Tc-MIBI planar scan demonstrated consistent result in 42 cases (68.9%), and those cases showed accurate localization in 90.5% (38/42). When both US and 99m Tc-MIBI SPECT/CT was consistent, all 37 lesions had been correctly indicated. No clinico-pathological features were suggested to influence in demonstrating the localization, other than only 99m Tc-MIBI SPECT/CT exhibited 100% sensitivity in ectopic glands. Combination of US and 99m Tc-MIBI SPECT/CT certainly contributes to the planning of minimally invasive operation in cases with pHPT by indicating correct localization of single adenoma.
机译:参考文献(22)By-By(8)我们评估了of-西他米比(99m Tc-MIBI)SPECT / CT在原发性甲状旁腺功能亢进(pHPT)病例中计划进行甲状旁腺切除术的有效性,并与平面闪烁显像和超声检查相比较目的是根据术前影像学研究确定适当的手术策略。回顾性分析了连续接受手术的75名pHPT患者。分析了术前影像学检查结果和手术结果。发现7例有多个增生腺,其中3例未发现负责腺。四例仅接受US扫描以进行术前成像。其余61例被发现患有单个腺瘤,并被包括在定位成像评估中。 US扫描,99m Tc-MIBI平面扫描和99m Tc-MIBI SPECT / CT分别显示了可评估病例的77.0%(47/61),75.4%(46/61)和88.5%(46/52)的准确定位。 US和99m Tc-MIBI平面扫描在42例病例中显示了一致的结果(68.9%),而这些病例显示了90.5%的准确定位(38/42)。当US和99m Tc-MIBI SPECT / CT一致时,所有37个病变均已正确显示。没有临床病理特征提示影响定位,除了仅99m Tc-MIBI SPECT / CT在异位腺中显示出100%的敏感性。 US和99m Tc-MIBI SPECT / CT的结合通过指示单个腺瘤的正确定位,无疑有助于规划pHPT患者的微创手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号